Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amneal Pharmaceuticals Inc (NY: AMRX ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Dec 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 5.710 (1) Ask (Size) 6.000 (1) Prev. Close 5.870 Today's Range N/A - N/A 52wk Range 3.960 - 5.800 Shares Outstanding 1,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California May 22, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Participate at Upcoming Investor Conference May 22, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Performance More News Read More Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade May 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts May 06, 2024 Via Benzinga Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement May 03, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Amneal Pharmaceuticals: Q4 Earnings Insights March 01, 2024 Via Benzinga Earnings Outlook For Amneal Pharmaceuticals February 29, 2024 Via Benzinga AMRX Stock Earnings: Amneal Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 03, 2024 Via InvestorPlace Amneal Reports First Quarter 2024 Financial Results May 03, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose April 24, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine April 16, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Report First Quarter 2024 Results on May 3, 2024 April 10, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 March 28, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension March 25, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday? March 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 01, 2024 Via InvestorPlace Earnings Scheduled For March 1, 2024 March 01, 2024 Via Benzinga Amneal Reports Fourth Quarter and Full Year 2023 Financial Results March 01, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203 February 27, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire 6 reasons to buy Teva Pharmaceuticals stock sooner than later February 26, 2024 Via MarketBeat Topics Lawsuit Exposures Financial Legal Amneal to Participate at Upcoming Investor Conference February 13, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024 January 31, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension January 10, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023 January 04, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference December 21, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
